|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1178641752 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m d |
| 007 |
cr ||||||||||| |
| 008 |
200725s2019 ii o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d YDX
|d REDDC
|d OCLCO
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d HF9
|
| 019 |
|
|
|a 1178640902
|a 1183721813
|
| 020 |
|
|
|a 9789390020355
|
| 020 |
|
|
|a 9390020352
|
| 020 |
|
|
|z 9789352705931
|
| 020 |
|
|
|z 9352705939
|
| 020 |
|
|
|z 9789352709724
|
| 020 |
|
|
|z 9352709721
|
| 020 |
|
|
|a 9789390281237
|q (electronic bk.)
|
| 020 |
|
|
|a 9390281237
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000069466883
|
| 035 |
|
|
|a (OCoLC)1178641752
|z (OCoLC)1178640902
|z (OCoLC)1183721813
|
| 050 |
|
4 |
|a RL321
|b .T466 2019
|
| 082 |
0 |
4 |
|a 616.526
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Thomas, Jayakar.
|
| 245 |
1 |
0 |
|a Year Book of Dermatology - 2018 Psoriasis
|h [electronic resource].
|
| 260 |
|
|
|a Delhi :
|b Jaypee Brothers Medical Publishers,
|c 2019.
|
| 300 |
|
|
|a 1 online resource (179 p.)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Cover -- Book Title -- Copyright Page -- Dedicated -- Contributors -- Foreword -- Preface -- Contents -- Article-1: Apremilast in Psoriasis-A Prospective Real-world Study -- Article-2: Comparative Effectiveness of Abatacept, Apremilast, Secukinumab and Ustekinumab Treatment of Psoriatic Arthritis: A Systematic Review and Network Meta-analysis -- Article-3: Management of Common Side Effects of Apremilast -- Article-4: Apremilast for the Treatment of Moderate-to-Severe Palmoplantar Psoriasis: Results from a Double-Blind, Placebo-Controlled, Randomized Study
|
| 505 |
8 |
|
|a Article-5: Long-term Safety and Tolerability of Apremilast in Patients with Psoriasis: Pooled Safety Analysis for ≥156 Weeks from 2 Phase 3, Randomized Controlled Trials (ESTEEM 1 and 2) -- Article-6: Secukinumab and Apremilast Combination Therapy for Recalcitrant Psoriasis -- Article-7: Apremilast: A Review in Psoriasis and Psoriatic Arthritis -- Article-8: Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity
|
| 505 |
8 |
|
|a Article-9: Long-term Real-life Safety Profile and Effectiveness of Fumaric Acid Esters in Psoriasis Patients: A Single-Centre, Retrospective, Observational Study -- Article-10: Association between Circulating 25-hydroxyvitamin D Levels and Psoriasis, and Correlation with Disease Severity: A Metaanalysis -- Article-11: Maintenance of Skin Clearance with Ixekizumab Treatment of Psoriasis: Three-Year Results from the UNCOVER-3 Study -- Article-12: Psoriasis and the Risk of Diabetes: A Prospective Populationbased Cohort Study
|
| 505 |
8 |
|
|a Article-13: Psoriatic Patients with Chronic Viral Hepatitis do not have an Increased Risk of Liver Cirrhosis Despite Long-term Methotrexate Use: Real-world Data from a Nationwide Cohort Study in Taiwan -- Article-14: Reporting of Outcomes in Randomized Controlled Trials on Nail Psoriasis: A Systematic Review -- Article-15: Risk of Cancer in Patients with Psoriasis on Biological Therapies: A Systematic Review -- Article-16: Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
|
| 505 |
8 |
|
|a Article-17: Secukinumab Treatment of Moderate to Severe Plaque Psoriasis in Routine Clinical Care: Real-life Data of Prior and Concomitant Use of Psoriasis Treatments from the PROSPECT Study -- Article-18: Serum Levels of Psoriasin (S100A7) and Koebnerisin (S100A15) as Potential Markers of Atherosclerosis in Patients with Psoriasis -- Article-19: Simulating the Life Course of Psoriasis Patients: The Interplay between Therapy Intervention and Marital Status -- Article-20: Smoking Paradox in the Development of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Study
|
| 500 |
|
|
|a Article-21: Stricturing and Fistulizing Crohn's Disease is Associated with Anti-tumor Necrosis Factor-induced Psoriasis in Patients with Inflammatory Bowel Disease
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Psoriasis.
|
| 650 |
|
2 |
|a Psoriasis
|
| 650 |
|
6 |
|a Psoriasis.
|
| 650 |
|
7 |
|a Psoriasis
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Thomas, Jayakar
|t Year Book of Dermatology - 2018 Psoriasis
|d Delhi : Jaypee Brothers Medical Publishers,c2019
|z 9789352705931
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6267664
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6267664
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16858774
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16885856
|
| 994 |
|
|
|a 92
|b IZTAP
|
